🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Dermatitis, Atopic

A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema) NCT07355075Phase 2, Phase 31 site📍 Irving Turn Therapeutics · Tests: GX-03, Vehicle Multi-modal Quantitative Imaging of the Skin NCT06989216n/a3 sites📍 Stockholm📍 Stockholm📍 Stockholm HJN Sverige AB/Neko Health Randomized, Blinded, Placebo-Controlled Evaluation of BioAmicus Complete NCT07444008NA1 site📍 Saint Petersburg NovoNatum Ltd · Tests: BioAmicus Complete, Placebo Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis NCT06801821n/a1 site📍 Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome NCT07242638Phase 21 site📍 New York Icahn School of Medicine at Mount Sinai · Tests: Abrocitinib Frequency of Palpebral Involvement in Adult With Atopic Dermatitis NCT04826744n/a2 sites📍 Lille📍 Rouen University Hospital, Lille · Tests: Standard dermatology consultation A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients NCT06946641Phase 11 site📍 Beijing Shanghai Qilu Pharmaceutical Research and Development Cente… · Tests: QLS12010, Placebo Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis NCT07298395Phase 232 sites📍 Birmingham📍 Hot Springs📍 Beverly Hills Enveda Therapeutics · Tests: ENV-294, Placebo China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project NCT05316805n/a1 site📍 Beijing Peking University First Hospital A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis NCT07598383Phase 21 site📍 Hangzhou Jiangsu vcare pharmaceutical technology co., LTD · Tests: VC005 group, VC005 Placebo group Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis NCT06934252Phase 119 sites📍 Belconnen📍 Albion📍 Blacktown TRex Bio, Inc. · Tests: TRB-061, TRB-061, TRB-061, Placebo Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis NCT06880276Phase 31 site📍 Shenyang Qilu Pharmaceutical Co., Ltd. · Tests: 1.5% QLM3003 ointment, 2% QLM3003 ointment, QLM3003 Placebo A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD) NCT07239947Phase 110 sites📍 Hefei📍 Wuhu📍 Beijing Bambusa Therapeutics · Tests: BBT001, Placebo Prospective Longitudinal Observational Research in Atopic Dermatitis NCT04240522n/a1 site📍 Zurich University of Zurich Effect of an Emollient Cream Containing a Milk Bioactive Peptide on Clinical Signs, Pruritus and Bacterial Colonization of Mild Atopic Dermatitis Skin Lesions in Pediatric Population NCT07259343NA1 site📍 Aguascalientes Universidad Autónoma de Aguascalientes · Tests: glycomacropeptide, emollient cream Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic Dermatitis NCT07316465NA1 site📍 Jette Universitair Ziekenhuis Brussel · Tests: Development of atopic dermatitis with/without IgE autoantibodies Natural History and Genetics of Food Allergy and Related Conditions NCT02504853n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis NCT07037901Phase 230 sites📍 Lancaster📍 Los Angeles📍 Ocala Inmagene LLC · Tests: IMG-007, Placebo Novel Skin Barrier Product Versus Petrolatum for Skin Barrier Dysfunction NCT07183423NA1 site📍 Makati City Makati Medical Center · Tests: Novel barrier repair topical product, Petrolatum Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic Dermatitis NCT07573735n/a1 site📍 Nanjing Zhongda Hospital · Tests: blood sampling Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Subjects With Moderate-to-severe Atopic Dermatitis NCT07762833Phase 31 site📍 Hangzhou Galderma R&D · Tests: Nemolizumab 30 mg, Placebo Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis NCT07042126Phase 33 sites📍 Beijing📍 Jinhua📍 Nanchang Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · Tests: 611, Matching placebo Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis NCT06982352Phase 13 sites📍 Fargo📍 Dallas📍 Amman LAPIX Therapeutics Inc. · Tests: LPX-TI641, Placebo A Study to Observe How Pediatric Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions Respond to Dupilumab Treatment NCT06192563n/a9 sites📍 Bologna📍 Brescia📍 Florence Sanofi · Tests: Dupilumab SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY) NCT07021495n/a8 sites📍 Nijmegen📍 Maastricht📍 Amsterdam Leiden University Medical Center Dupixent and Narrowband UVB for Atopic Dermatitis NCT05285839Phase 41 site📍 East Windsor Psoriasis Treatment Center of Central New Jersey · Tests: Dupixent Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis NCT03835767Phase 21 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… · Tests: Peanut powder and Oat flour, Peanut flour and Oat flour (placebo for peanut flour), Dry Milk Powder and Corn Starch (pl… Registry for Systemic Eczema Treatments NCT06136767n/a1 site📍 Baltimore Johns Hopkins University A Study to Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe Atopic Dermatitis NCT07330934Phase 21 site📍 Beijing Innovent Biologics (Suzhou) Co. Ltd. · Tests: Dupilumab, Placebo, IBI356 A Study to Learn About the Study Medicine (Called Cibinqo) in People With Atopic Dermatitis NCT05391061n/a1 site📍 Seoul Pfizer · Tests: Abrocitinib
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy